Related Experiment Video
Updated: Jul 3, 2026
10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Vaccines against enterotoxigenic Escherichia coli
Ann-Mari Svennerholm1, Joshua Tobias
1Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Box 435, S-40530, Gothenburg, Sweden. ann-mari.svennerholm@microbio.gu.se
Expert Review of Vaccines
|July 31, 2008
Summary
Developing an effective enterotoxigenic Escherichia coli (ETEC) vaccine remains challenging, particularly for infants in developing nations. Current research focuses on improving existing ETEC vaccine candidates and creating novel ones for broader protection against ETEC diarrhea.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Enterotoxigenic Escherichia coli (ETEC) is a primary cause of diarrhea in young children in developing countries and travelers.
- ETEC pathogenesis involves colonization factors (CFs) and enterotoxins (heat-labile LT and heat-stable ST).
Purpose of the Study:
- To review the challenges and strategies in developing broad-spectrum ETEC vaccines.
- To highlight the need for effective vaccines in the most vulnerable populations, including infants and young children.
Main Methods:
- Review of current ETEC vaccine development strategies.
- Analysis of immunogenicity and efficacy data for ETEC candidate vaccines.
Main Results:
- Some ETEC vaccines show promise in adult travelers but lack efficacy in infants.
- No ETEC vaccine has proven effective in the critical target group of infants and young children in endemic areas.
Conclusions:
- Improving the immunogenicity of existing ETEC vaccine candidates is crucial.
- Development of new ETEC vaccine types is necessary to address the efficacy gap in young children.
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:25Cholera
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...